A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center, open label, dose titration, exploratory study to evaluate
efficacy and safety of CS-3150 in Japanese hypertensive patients with moderate renal
impairment. Primary endpoint is change from baseline in sitting systolic and diastolic blood
pressure.